Announcements Trials

Browse Landscape

Status

Terminated 4 Completed 4 Unknown 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Uterine Cervical Neoplasms 11 Prostatic Neoplasms 9 Uterine Neoplasms 2 Hyperthermia 2 Endometrial Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Rhabdomyosarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Locally Advanced Cervical Adenocarcinoma 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Directly Observed Therapy 1 Cervical Adenocarcinoma 1 Carcinoma, Renal Cell 1 Adenocarcinoma 1

Interventions

pembrolizumab 38 Blood Specimen Collection 38 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 17 Exercise 17 Carboplatin 17 Nivolumab 15 atezolizumab 14 Paclitaxel 14 Cisplatin 14 Drug Therapy 13 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 11 Trastuzumab 10 Pemetrexed 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Brachytherapy × Clear all

NCT01255748 2025-09-09

Registry Study for Radiation Therapy Outcomes

Proton Collaborative Group

40,000 enrolled

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡